Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression

• Status: Completed
• Trial end date: 2007-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine the effectiveness of ethyl-eicosapentanoic acid (ethyl-EPA), an omega-3 fatty acid, in treating depression.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Center for Complementary and Integrative Health (NCCIH)
• Treatments: Eicosapentaenoic acid ethyl ester

Criteria

Inclusion Criteria:

• Major depressive disorder

Exclusion Criteria:

• Serious comorbid psychiatric disorder

• Unstable medical illness

• Prior use of any omega-3 fatty acid product